Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias

Stopped early

Conditions studied: Idiopathic Interstitial Pneumonias

In brief

We hypothesize that a peripheral blood biomarker or biological signature (gene or protein expression pattern) of idiopathic interstitial pneumonias (IIPs) will simplify and improve the accuracy of diagnosis of IIP and diagnose individuals at an earlier, more treatable, stage of their disease.

Key facts

Study ID

NCT01151527

Run by

Duke University

People needed

269

Starts

2010-04-01

Expected to finish

2013-02-01

Last updated by the study team

2015-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Sporadic cases of Idiopathic Pulmonary Fibrosis and other types of Idiopathic Interstitial Pneumonias.
• Family members ( with or without clinical disease) with a family history of pulmonary fibrosis.

You may not qualify if…

• None.

Where it is running

• National Jewish Health — Denver, Colorado, United States
• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.